These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2456620

  • 1. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
    Coleman M, Armitage JO, Gaynor M, McDermott D, Weisenburger DD, Adler K, Beshevkin M, Silver RT, Reisman AM, Pasmantier MW.
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):23-33. PubMed ID: 2456620
    [Abstract] [Full Text] [Related]

  • 2. European experience with ifosfamide in lymphomas.
    von Kalle AK, Schaadt M, Diehl V.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [Abstract] [Full Text] [Related]

  • 3. Advances in chemotherapy for large cell lymphoma.
    Coleman M, Gerstein G, Topilow A, Lebowicz J, Berhardt B, Chiarieri D, Silver RT, Pasmantier MW.
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of CHOP and COP-BLAM chemotherapy in highly malignant non-Hodgkin's lymphoma].
    Gerhartz HH, Thiel E, Hiller E, Nerl C, Wilmanns W, Huhn D.
    Dtsch Med Wochenschr; 1986 Oct 03; 111(40):1511-5. PubMed ID: 2428572
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
    Niitsu N, Umeda M.
    Int J Hematol; 1994 Jul 03; 60(1):71-8. PubMed ID: 7522616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 10. [The COP-BLAM III therapy of non-Hodgkin's lymphoma].
    Arai N, Hara A, Umeda M, Shirai T.
    Rinsho Ketsueki; 1991 Nov 01; 32(11):1447-52. PubMed ID: 1721937
    [Abstract] [Full Text] [Related]

  • 11. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
    Niitsu N, Hara A, Umeda M, Shirai T.
    Rinsho Ketsueki; 1993 Jul 01; 34(7):829-34. PubMed ID: 7689661
    [Abstract] [Full Text] [Related]

  • 12. [The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1995 Feb 01; 36(2):84-90. PubMed ID: 7536279
    [Abstract] [Full Text] [Related]

  • 13. [ProMACE-MOPP vs. ProMACE-CytaBOM polychemotherapies in the treatment of large-cell and unclassifiable non-Hodgkin's lymphomas].
    Pieresca C, Gobbi PG, Bertoloni D, Grignani G, Rossi A, Legnani MC, Giordano M.
    Ann Ital Med Int; 1991 Feb 01; 6(3):267-72. PubMed ID: 1723289
    [Abstract] [Full Text] [Related]

  • 14. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1994 Nov 01; 35(11):1267-75. PubMed ID: 7529840
    [Abstract] [Full Text] [Related]

  • 15. Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
    Niitsu N, Umeda M.
    Eur J Haematol; 1996 Mar 01; 56(3):163-7. PubMed ID: 8598236
    [Abstract] [Full Text] [Related]

  • 16. [COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
    Niitsu N, Umeda M, Shirai T.
    Nihon Ronen Igakkai Zasshi; 1993 Sep 01; 30(9):753-8. PubMed ID: 7693992
    [Abstract] [Full Text] [Related]

  • 17. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
    Arai N, Hara A, Kaneko H, Umeda M, Shirai T.
    Nihon Ronen Igakkai Zasshi; 1991 Sep 01; 28(5):672-7. PubMed ID: 1721658
    [Abstract] [Full Text] [Related]

  • 18. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
    Niitsu N, Umeda M.
    Eur J Haematol; 1995 Aug 01; 55(2):88-92. PubMed ID: 7543059
    [Abstract] [Full Text] [Related]

  • 19. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
    Prokocimer M, Modan M, Rusoshansky S, Bairey O, Shaklai M.
    Anticancer Res; 1989 Aug 01; 9(4):1233-5. PubMed ID: 2479327
    [Abstract] [Full Text] [Related]

  • 20. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.
    Haematologica; 2000 Mar 01; 85(3):263-8. PubMed ID: 10702814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.